Summary
Overview
Work History
Education
Skills
Affiliations
Additional Information
Languages
Accomplishments
Peer Reviewed Publication
Manuscripts in process
Abstracts
References
Timeline
Generic
Mohammad Othman

Mohammad Othman

Bloomfield Hills,MI

Summary

Personal profile: A highly motivated, well-experienced pathologist with extensive background in surgical pathology and GYN pathology. Board certified in Anatomic and clinical pathology. Completed three fellowships in MD Anderson Cancer Center (surgical oncologic pathology, GI Cancer biomarker and Gynecological pathology fellowships). Eleven years’ experience after fellowship.

Overview

21
21
years of professional experience

Work History

Surgical Pathologist

Henry Ford Health System
Detroit, MI
10.2018 - Current

Surgical Pathologist

Fairview Pathology
Dearborn, MI
05.2016 - 12.2018

Anatomic and Clinical Pathologist

Lake Huron medical Center
Port Huron, MI
09.2013 - 09.2018

Consultant Histopathologist

Riyadh Military Hospital
Riyadh, KSA, KSA
08.2011 - 08.2013

Medical Technologist

Carolina Medical Lab
Charlotte, NC
04.2003 - 06.2004

Lab Director

Ford Bio Medical laboratory Inc
Dearborn, MI
03.2022 - Current
  • Developed and implemented laboratory safety procedures to ensure compliance with regulatory requirements.
  • Directed the design, development, and implementation of new laboratory technologies and processes.
  • Monitored lab operations for quality control purposes.
  • Oversaw data collection, analysis, interpretation, and reporting of results from experiments conducted in the lab.
  • Maintained records documenting all activities performed by members of the laboratory team.
  • Performed troubleshooting duties when necessary to resolve technical issues arising during experiments or other tasks associated with running a successful laboratory environment.

Lab Director

Prime Diagnostics Labs
Dearborn Heights, MI
01.2021 - Current
  • Developed and implemented laboratory safety procedures to ensure compliance with regulatory requirements.
  • Directed the design, development, and implementation of new laboratory technologies and processes.
  • Monitored lab operations for quality control purposes.
  • Oversaw data collection, analysis, interpretation, and reporting of results from experiments conducted in the lab.
  • Maintained records documenting all activities performed by members of the laboratory team.
  • Performed troubleshooting duties when necessary to resolve technical issues arising during experiments or other tasks associated with running a successful laboratory environment.

Education

GYN Pathology Fellow -

UT MD Anderson Cancer Center
Houston, TX
06.2011

Cancer Biomarker Fellow -

UT MD Anderson Cancer Center
Houston, TX
06.2010

Oncologic Pathology Fellow -

UT MD Anderson Cancer Center
Houston, TX
06.2009

AP/CP Pathology Resident PGY2-4 -

Wayne State University
Detroit, MI
06.2008

AP/CP Pathology Resident PGY1 -

University of Illinois At Chicago
Chicago, IL
07.2004

Post graduate study - Pathology Residency

University of Damascus
Damascus, Syria
09.2001

M.D. -

University of Damascus
Damascus, Syria
07.1997

Skills

  • Diagnostic testings for highly complicated cancer cases as well as benign cases
  • Running Tumor Boards
  • Teaching Pathology Residents
  • Teaching Medical students

Affiliations

American Society for Clinical Pathologists (ASCP) College of American Pathologists (CAP) United State and Canadian Academy of Pathology (USCAP) Michigan Society of Pathologists (MSP) Michigan State Medical Society (MSMS)

Additional Information

  • American Board Of Pathology, Anatomic and Clinical
  • Michigan Medical License
  • US Citizen

Languages

English
Native/ Bilingual
Arabic
Native/ Bilingual

Accomplishments

· Currently working in at Henry Ford Health System, very high volume and complex GYN Pathology cases.

· During Fellowships in MD Anderson:

- Studying mesonephric Adenocarcinoma of the Uterine Cervix (in the process of submission for publication).

- Studying intrabiliary growth of liver metastases (The American Journal of Surgical Pathology, October 2013).

- Studying the expression of Aldehyde dehydrogenase in small bowel adenocarcinoma.

- Presentations in GYN path journal club, head and neck tumors and central nervous system tumors.

· In the previous position in Riyadh Military Hospital, Riyadh, KSA: Consultant academic histopathologist with focus on GYN pathology.

- Publishing a gross manual that has been used by Pathology residents and staff.

- This manual made the gross report more standardized by using American standards and following three-paragraph system (adopted by MD Anderson cancer center), gave the residents and pathology assistants an easy and accurate guidelines in gross pathology and enforced few unrecognized concepts in gross pathology that affect the staging, therapy and may determine prognosis (examples: radial margins especially in rectosigmoid cancer and the concept of stage 4 versus stage 3 with unresectable disease, sampling of renal sinus in Renal tumors, etc…)

-Improving diagnostic skills in the department by following specific morphologic and immunophenotypic criteria in both common and rare tumor cases as well as using CAP standards in reporting cancer cases.

- Examples: Common tumor cases:

1. Preventing unnecessary radical hysterectomies in few cases after differentiating endometrial adenocarcinoma from cervical adenocarcinoma by using three ancillary studies (ER, Vimentin, P16 or HPV CISH)

2. Avoiding unnecessary surgical staging procedures and performing them only when it is needed, through the differentiation between different types of endometrial adenocarcinoma in limited sampling (ex: P53 null phenotype).

3. Grading endometrial adenocarcinoma in limited samples.

4. Proper diagnosis of low vs. high-grade serous carcinoma of the ovary using two-tier system (Malpica, et al)

- Rare tumor consultations:

1. Cases of carcinoma of the lower uterine segment clinically suspected to be cervical cancer one of them was associated with micro satellite instability (MSI).

2. Rare histologic type of granulosa cell tumor (diffuse pattern) may be diagnoses by using as simple as reticulin stain (in addition to the usual immunostain pattern)

3. A case of small cell carcinoma of hypercalcemic type in a young lady who was suspected to have granulosa cell tumor

4. A case of ovarian transitional cell carcinoma thought to be High grade serous carcinoma.

5. Two cases of Breast myofibroblastoma, one of which had palisaded pattern thought to be schwannoma.

6. Cases of MSI in young patients with colon cancer

In September and October of 2015 I participated as an investigator in Ventana study (Diagnostic Utility study for CINtec Histology, a multi-reader, multi-case Study).

· Previous position at Lake Huron Medical center: General surgical pathology and Cytopathology, extensive clinical experience in signing out both neoplastic and non-neoplastic cases.

· Examples of these cases:

1. Gastric adenocarcinoma mimicking benign ulcer.

2. Autoimmune atrophic gastritis with neuroendocrine hyperplasia.

3. Focal neuroendocrine carcinoma in a background of tubular adenoma in colon.

4. MSI in colon cancer.

5. Lymphocytic and ischemic colitis.

6. Inflammatory bowel disease.

8. Gallbladder adenoma with high-grade dysplasia.

9. Multifocal high-grade dysplasia in gallbladder.

10. Incidental paraganglioma in gallbladder.

11. Low VS. High-grade VS indefinite for dysplasia in Barrett's esophagus.

12. LCIS with aberrant E-cadherin expression in breast.

13. ADH in a gynecomastia (male breast).

14. Skin cancer.

15. Endometrioid VS serous carcinoma in endometrium.

16. Band-like P16 expression and proper diagnosis of high-grade dysplasia in cervix.

17. Partial mole

18. Papillary proliferation of endometrium with complex architectural pattern and secretory changes (complex papillary hyperplasia).

Currently at Henry Ford Health System, GYN pathology (main) and GI pathology (secondary), examples:

1. Proper diagnosing endometrial adenocarcinoma, endometrioid type (POLE ultra-mutated, MMR deficient)

2. High grade endometrial carcinoma (endometrioid FIGO grade 3 vs. Undifferentiated/ dedifferentiated, corded and hyalinized endometrioid carcinoma vs. MMMT, etc..)

3. Endometrial vs. endocervical adenocarcinoma

4. Uterine mesenchymal tumors including FH deficient leiomyomata and PEComas

5. Endocervical adenocarcinoma (HPV associated vs. HPV independent carcinoma)

6. Vulvar inflammatory, preneoplastic and neoplastic lesions

7. Ovarian tumors

Peer Reviewed Publication

1- S Bandyopadhyay, N Kilinc, P Vyas, M Othman, J Cheng, NV adsay. Criteria for distinction of pancreatic adenocarcinoma from chronic pancreatitis (CP). Modern Pathology 16(1): 271A, 2003

2-  F Khanani, N Kilinc, H Nassar, M Othman, P Bejarano, J Cheng, NV Adsay. Mesenchymal lesions involving the pancreas. Modern Pathology 16(1): 279A, 2003

3- P Vyas, A Andea, M Othman, J Cheng, NV Adsay. A modified approach to dissection of pancreatoduodenectomy (PD) specimens for a more accurate but practical assessment of the clinically relevant pathologic parameters. Modern Pathology 16(1): 288A, 2003

4- M. Othman , O. Basturk , G. Groisman ,A. Krasinskas , N.V. Adsay Departments of Pathology, Squamoid cyst of pancreatic ducts: a distinct type of cystic lesion in the pancreas, Am J Surg Pathol. 2007 Feb;31(2):291-7

5- J.Estrella, M.Othman, S Abraham, Intrabiliary growth of liver metastases. Am J Surg Pathol. 2013 Oct;37(10):1571-9

6- Li Lei, M.Othman, Rashid A, Wang H, Li Z, Katz MH, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB, Wang H. Solid pseudopapillary neoplasm of the pancreas with prominent atypical multinucleated giant tumour cells. Histopathology. 2013 Feb;62(3):465-71

Manuscripts in process

  • M.Othman, E. Euscher, M.D., A. Malpica, Mesonephric Adenocarcinoma of the Uterine Cervix: An Update of the Immunohistochemical Profile

Abstracts

HistopathologistMesonephricUpdate of the Immunohistochemical Profile (USCAP. San Antonio, TX, 2011)

RashidAbbruzzeseEuscherMesonephricSarkarductal

References

References available upon request.

Timeline

Lab Director

Ford Bio Medical laboratory Inc
03.2022 - Current

Lab Director

Prime Diagnostics Labs
01.2021 - Current

Surgical Pathologist

Henry Ford Health System
10.2018 - Current

Surgical Pathologist

Fairview Pathology
05.2016 - 12.2018

Anatomic and Clinical Pathologist

Lake Huron medical Center
09.2013 - 09.2018

Consultant Histopathologist

Riyadh Military Hospital
08.2011 - 08.2013

Medical Technologist

Carolina Medical Lab
04.2003 - 06.2004

GYN Pathology Fellow -

UT MD Anderson Cancer Center

Cancer Biomarker Fellow -

UT MD Anderson Cancer Center

Oncologic Pathology Fellow -

UT MD Anderson Cancer Center

AP/CP Pathology Resident PGY2-4 -

Wayne State University

AP/CP Pathology Resident PGY1 -

University of Illinois At Chicago

Post graduate study - Pathology Residency

University of Damascus

M.D. -

University of Damascus
Mohammad Othman